ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 277 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR Breast Cancer Survivor Driven from Her Home by Noxious Gases from... June 11, 2021 Large Study Confirms that HPV Vaccine Prevents Cervical Cancer October 14, 2020 Life beyond cancer: Improving the long term side effects for children... September 22, 2022 EMA Recommends Extension of Indications for Ribociclib to Include Use in... November 5, 2024 Load more HOT NEWS Ponatinib Effectively Treats Newly Diagnosed Acute Lymphoblastic Leukemia: The ASCO Plenary... Phase II LCMC3 Study of Neoadjuvant Atezolizumab Met Primary Endpoint with... Got the COVID Blues? Airbrushed Magazines Hurt the Body Image of Young Women — Here’s...
